Physician profile
Michael T Galloway
NPI 1437109949
$1,711.13
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $297 · 2021: $116 · 2022: $282 · 2023: $183 · 2024: $211 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $879.43 | 2019-2024 | Aveir, Gallant |
| Heartflow, INC. | $273.29 | 2020-2023 | Ffrct |
| Medtronic, INC. | $194.06 | 2022-2025 | Micra |
| Actelion Pharmaceuticals US, INC. | $124.40 | 2023 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $67.40 | 2025 | Eliquis |
| Pfizer INC. | $66.31 | 2022 | |
| Irhythm Technologies, INC. | $28.14 | 2024 | Zio Xt Patch |
| Amgen INC. | $25.88 | 2019 | |
| Boston Scientific Corporation | $13.88 | 2024 | Latitude Communicator Power Supply |
| Regeneron Healthcare Solutions, INC. | $13.64 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.47 | 2019 | |
| Medtronic Vascular, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.